Model
Edge
Lineage Cell Therapeutics
0001878732
Filing Type
4
Filing Date
2/11/2024
Updated
2/12/24, 2:30 PM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership